Publisher
Public Library of Science (PLoS)
Reference29 articles.
1. Effects of proprotein convertase subtilisin/kexin type 9 antibodies in adults with hypercholesterolemia: a systematic review and meta-analysis;EP Navarese;Ann Intern Med,2015
2. Are PCSK9 inhibitors the next breakthrough in the cardiovascular field?;RP Giugliano;J Am Coll Cardiol,2015
3. US Food and Drug Administration. FDA approves Repatha to treat certain patients with high cholesterol. 2015. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm460082.htm.
4. US Food and Drug Administration. FDA approves Praluent to treat certain patients with high cholesterol. 2015. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm455883.htm.
5. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events;MS Sabatine;N Engl J Med,2015
Cited by
68 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献